The Invisible Patients: Rewriting the Story of Women in Clinical Science. Part 2: The Evolution Underway
Today, we stand at a pivotal moment. The landscape of clinical research in women's health is transforming, driven by advocacy, policy reform, and a growing recognition that medicine cannot be universal if it ignores biological sex and gender as critical variables. This is the story of where we've been and the promising progress ahead.
The Invisible Patients: Rewriting the Story of Women in Clinical Science. Part 1: The Legacy of Neglect
Today, we stand at a pivotal moment. The landscape of clinical research in women's health is transforming, driven by advocacy, policy reform, and a growing recognition that medicine cannot be universal if it ignores biological sex and gender as critical variables. This is the story of where we've been and the promising progress ahead.
The Hormone Paradox: Why the Gold Standard for Menopause Doesn't Work for Everyone
Progesterone Intolerance is the silent barrier to HRT compliance - and a massive, overlooked opportunity for wellness innovation.
Why SIBO May Be the Hidden Driver Behind IBS - and the Next Frontier for Wellness Innovation
As consumers demand more than marketing slogans about “gut balance,” SIBO stands at the intersection of science and opportunity.
From Promise to Proof: How Clinical-Grade Evidence Is Rewriting Beauty’s Playbook - Part II
Pharma-Beauty’s evolution: decentralization, data, and the new standard for proof
From Promise to Proof: How Clinical-Grade Evidence Is Rewriting Beauty’s Playbook - Part I
Pharma-Beauty’s evolution: why validated science, decentralized methods, and transparent data reporting are shaping the leaders of tomorrow.